ENTITY

Spero Therapeutics (SPRO US)

3
Analysis
Health CareUnited States
Spero Therapeutics, Inc. operates as a biopharmaceutical company. The Company focuses on identifying, developing, and commercializing novel treatments for MDR bacterial infections. Spero Therapeutics also offers a technology platform that develops drugs to expand the spectrum and potency of existing antibiotics. Spero Therapeutics serves customers worldwide.
more
Company Event14 Mar 2026 04:00 • Upcoming
Add To Calendar
Company Event14 Nov 2025 05:00 • Upcoming
Add To Calendar
Company Event13 Aug 2025 04:30 • Latest
Company Event16 Jun 2025 19:00 • Upcoming
Add To Calendar
Company Event14 May 2025 04:00 • Upcoming
Add To Calendar
x